Cited by 117Retinal Diseases and TreatmentsAngiogenesis and VEGF in CancerRetinal Imaging and Analysis

Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration

Open access
Ebrahem, Quteba, Renganathan, Kutralanathan, Sears, Jonathan, Vasanji, Amit, Gu, Xiaorong, Lu, Liang, Salomon, Robert G., Crabb, John W. +1 more·2006·Proceedings of the National Academy of Sciences

Abstract

Choroidal neovascularization (CNV), the advanced stage of age-related macular degeneration (AMD), accounts for >80% of vision loss in AMD. Carboxyethylpyrrole (CEP) protein modifications, uniquely generated from oxidation of docosahexaenoate-containing lipids, are more abundant in Bruch's membrane from AMD eyes. We tested the hypothesis that CEP protein adducts stimulate angiogenesis and possibly contribute to CNV in AMD. Human serum albumin (HSA) or acetyl-Gly-Lys-O-methyl ester (dipeptide) were chemically modified to yield CEP-modified HSA (CEP-HSA) or CEP-dipeptide. The in vivo angiogenic properties of CEP-HSA and CEP-dipeptide were demonstrated by using the chick chorioallantoic membrane and rat corneal micropocket assays. Low picomole amounts of CEP-HSA and CEP-dipeptide stimulated neovascularization. Monoclonal anti-CEP antibody neutralized limbal vessel growth stimulated by CEP-HSA, whereas anti-VEGF antibody was found to only partially neutralize vessel growth. Subretinal injections of CEP-modified mouse serum albumin exacerbated laser-induced CNV in mice. In vitro treatments of human retinal pigment epithelial cells with CEP-dipeptide or CEP-HSA did not induce increased VEGF secretion. Overall, these results suggest that CEP-induced angiogenesis utilizes VEGF-independent pathways and that anti-CEP therapeutic modalities might be of value in limiting CNV in AMD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0601552103

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [1]Macular Photocoagulation Study Group. Arch. Ophthalmol. 1991;109:1242–1257. [PubMed] [Google Scholar]
  2. [5]Winkler B. S., Boulton M. E., Gottsch J. D., Sternberg P. Mol. Vis. 1999;5:32. [PMC free article] [PubMed] [Google Scholar]
  3. [6]Seddon J. M., Willett W. C., Speizer F. E., Hankinson S. E. J. Am. Med. Assoc. 1996;276:1141–1146. [PubMed] [Google Scholar]
  4. [20]Hoffmann S., Masood R., Zhang Y., He S., Ryan S. J., Gill P., Hinton D. R. Invest. Ophthalmol. Vis. Sci. 2000;41:2389–2393. [PubMed] [Google Scholar]
  5. [28]Handa J. T., Verzijl N., Matsunaga H., Aotaki-Keen A., Lutty G. A., te Koppele J. M., Miyata T., Hjelmeland L. M. Invest. Ophthalmol. Vis. Sci. 1999;40:775–779. [PubMed] [Google Scholar]
  6. [32]Anonymous. Ophthalmology. 1991;98:757–765. [Google Scholar]

Cited by

Sorted by citations

Authors
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B.
Affiliations
  • Cleveland Clinic (US)
  • *Cole Eye Institute and
  • Case Western Reserve University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2006-09-05
Volume
103
Issue
36
Pages
13480-13484
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1993045845
Cited by
117
References
42
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 6 · 2014: 13 · 2013: 9 · 2012: 12
FWCI
7.11
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (EY06603)
  • National Eye Institute (EY014239, EY 015638, EY06603, F32EY006603, R01EY016490, EY016490, R01EY006603, R24EY015638, R01EY014239)
  • National Cancer Institute (R01CA106415, CA106415)
  • National Institute of General Medical Sciences (R01GM021249, GM 21249)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
protein oxidation, choroidal neovascularization, age-related macular degeneration, angiogenesis, Bruch's membrane, human serum albumin, VEGF-independent angiogenesis, retinal pigment epithelium, laser-induced CNV
MeSH terms
Aged, 80 and over, Allantois, Animals, Cell Line, Cells, Cultured, Chick Embryo, Child, Chorion, Dose-Response Relationship, Drug, Humans, Macular Degeneration, Mice, Inbred C57BL, Middle Aged, Oxidation-Reduction, Pigment Epithelium of Eye, Pyrroles, Serum Albumin, Bruch Membrane, Laser Coagulation, Rats, Sprague-Dawley, Neovascularization, Physiologic, Cell Culture Techniques, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review